The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Cell cycle checkpoints and their inactivation in human cancer
Open accessAbstract
Checkpoints are mechanisms that regulate progression through the cell cycle insuring that each step takes place only once and in the right sequence. Mutations of checkpoint proteins are frequent in all types of cancer as defects in cell cycle control can lead to genetic instability. This review will focus on three major areas of cell cycle transition control, with particular attention to the alterations found in human cancer. These areas include the G1/S transition, where most cancer‐related defects occur, the G2/M checkpoint and its activation in response to DNA damage, and the spindle checkpoint.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379 · cited 2×
“In short, cycD acts as a growth sensor and provides a link between mitogenic stimuli and the cell cycle machinery (Sherr 1996).”
BackgroundThe retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862 · cited 1×
“The G1/S transition is regulated by the phosphorylation state of the tumour suppressor Rb (Ewen 1994; Weinberg 1995).”
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785 · cited 1×
“All three kinases have been proposed to mediate p53 phosphorylation following DNA damage, although the exact function of this modi®cation remains to be de®ned (Savitsky et al. 1995; Siliciano et al. 1997; Canman et al. 1998).”
BackgroundThe regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Thymocyte apoptosis induced by p53-dependent and independent pathways
Clarke, A. R., Purdie, C. A., Harrison, D. J., Morris, R. G., Bird, C. C., Hooper, M. L., & Wyllie, A. H. (1993) · Nature · doi:10.1038/362849a0 · Cited by 2,271
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6
Yonish-Rouach, E., Resnftzky, D., Lotem, J., Sachs, L., Kimchi, A., & Oren, M. (1991) · Nature · doi:10.1038/352345a0 · Cited by 2,079
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Genetic instability in colorectal cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386623a0 · Cited by 1,986
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950 · cited 1×
“…ARF, Alternative Reading Frame; AT, Ataxia Telengiectasia; APC, Anaphase Promoting Complex. p16INK4a (Serrano, Hannon & Beach 1993) p15INK4b (Hannon & Beach 1994), p18INK4c (Guan et al. 1994), and p19INK4d (Chan et al. 1995; Hirai & Sherr 1996), which bind and inhibit cdk4-and…”
BackgroundPagano, M., Tam, S. W., Theodoras, A. M., Beer-Romero, P., Del Sal, G., Chau, V., Yew, P. R., Draetta, G. F., & Rolfe, M. (1995) · Science · doi:10.1126/science.7624798 · Cited by 1,817
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
Carrano, A. C., Eytan, E., Hershko, A., & Pagano, M. (1999) · Nature Cell Biology · doi:10.1038/12013 · Cited by 1,543
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,486
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
DNA Damage-Induced Activation of p53 by the Checkpoint Kinase Chk2
Hirao, A., Kong, Y.-Y., Matsuoka, S., Wakeham, A., Ruland, J., Yoshida, H., Liu, D., Elledge, S. J., & Mak, T. W. (2000) · Science · doi:10.1126/science.287.5459.1824 · Cited by 1,285
How Proteolysis Drives the Cell Cycle
King, R. W., Deshaies, R. J., Peters, J.-M., & Kirschner, M. W. (1996) · Science · doi:10.1126/science.274.5293.1652 · Cited by 1,273
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Retinoblastoma protein recruits histone deacetylase to repress transcription
Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1998) · Nature · doi:10.1038/35404 · Cited by 1,230
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
Srivastava, S., Zou, Z., Pirollo, K., Blattner, W., & Chang, E. H. (1990) · Nature · doi:10.1038/348747a0 · Cited by 1,211
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Cheng, M., Olivier, P., Diehl, J. A., Fero, M., Roussel, M. F., Roberts, J. M., & Sherr, C. J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1571 · Cited by 1,142 · cited 1×
“Paradoxically, at lower concentrations p21 and p27 can also facilitate the formation of the cycD/cdk4 kinase complex, that retains its ability to phosphorylate the Retinoblastoma (Rb) protein (Labaer et al. 1997; Cheng et al. 1999; Parry et al. 1999).”
BackgroundHarbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
Loda, M., Cukor, B., Tam, S. W., Lavin, P., Fiorentinc, M., Draetta, G. F., Jessup, J. M., & Pagano, M. (1997) · Nature Medicine · doi:10.1038/nm0297-231 · Cited by 1,031
Cortez, D., Wang, Y., Qin, J., & Elledge, S. J. (1999) · Science · doi:10.1126/science.286.5442.1162 · Cited by 1,020
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C. (2000) · Genes & Development · doi:10.1101/gad.14.3.289 · Cited by 972
Rb Interacts with Histone Deacetylase to Repress Transcription
Luo, R. X., Postigo, A. A., & Dean, D. C. (1998) · Cell · doi:10.1016/s0092-8674(00)80940-x · Cited by 960
Matsuoka, S., Edwards, M. C., Bai, C., Parker, S., Zhang, P., Baldini, A., Harper, J. W., & Elledge, S. J. (1995) · Genes & Development · doi:10.1101/gad.9.6.650 · Cited by 952
Retinoblastoma protein represses transcription by recruiting a histone deacetylase
Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D., & Harel-Bellan, A. (1998) · Nature · doi:10.1038/35410 · Cited by 909
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
Tanaka, H., Arakawa, H., Yamaguchi, T., Shiraishi, K., Fukuda, S., Matsui, K., Takei, Y., & Nakamura, Y. (2000) · Nature · doi:10.1038/35003506 · Cited by 904
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Lee, M. H., Reynisdóttir, I., & Massagué, J. (1995) · Genes & Development · doi:10.1101/gad.9.6.639 · Cited by 889
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. (1994) · Nature Genetics · doi:10.1038/ng0994-22 · Cited by 855
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
Zuo, L., Weger, J., Yang, Q., Goldstein, A. M., Tucker, M. A., Walker, G. J., Hayward, N., & Dracopoli, N. C. (1996) · Nature Genetics · doi:10.1038/ng0196-97 · Cited by 818 · cited 1×
“…in familial melanomas are found in the p16 gene (Hussussian et al. 1994; Kamb et al. 1994), as well as in cdk4, with the effect of affecting its binding to p16 (WoÈ lfel et al. 1995; Zuo et al. 1996), strongly suggesting that p16 also has an important role in preventing melanoma susceptibility.”
BackgroundDNA damage induces phosphorylation of the amino terminus of p53
Siliciano, J. D., Canman, C. E., Taya, Y., Sakaguchi, K., Appella, E., & Kastan, M. B. (1997) · Genes & Development · doi:10.1101/gad.11.24.3471 · Cited by 818 · cited 1×
“All three kinases have been proposed to mediate p53 phosphorylation following DNA damage, although the exact function of this modi®cation remains to be de®ned (Savitsky et al. 1995; Siliciano et al. 1997; Canman et al. 1998).”
BackgroundChk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53
Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D. (2000) · Genes & Development · doi:10.1101/gad.14.3.278 · Cited by 805
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit
Gu, Y., Turck, C. W., & Morgan, D. O. (1993) · Nature · doi:10.1038/366707a0 · Cited by 764
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Gillett, C., Fantl, V., Smith, D., Fisher, C., Bartek, J. J., Dickson, C., Barnes, D. M., & Peters, G. (1994) · PubMed · Cited by 750
Guan, K. L., Jenkins, C. W., Li, Y., Nichols, M. A., Wu, X., O'Keefe, C. L., Matera, A. G., & Xiong, Y. (1994) · Genes & Development · doi:10.1101/gad.8.24.2939 · Cited by 714
Hoffmann, I., Clarke, P. R., Marcote, M. J., Karsenti, E., & Draetta, G. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05631.x · Cited by 684
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
GADD45 induction of a G 2 /M cell cycle checkpoint
Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O’Connor, P. M., Fornace, A. J., & Harris, C. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3706 · Cited by 634
Paulovich, A. G., Toczyski, D. P., & Hartwell, L. H. (1997) · Cell · doi:10.1016/s0092-8674(00)81870-x · Cited by 616
Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
Montagnoli, A., Fiore, F., Eytan, E., Carrano, A. C., Draetta, G. F., Hershko, A., & Pagano, M. (1999) · Genes & Development · doi:10.1101/gad.13.9.1181 · Cited by 597
Fang, G., Yu, H., & Kirschner, M. W. (1998) · Genes & Development · doi:10.1101/gad.12.12.1871 · Cited by 594
Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein
Lopez-Girona, A., Furnari, B., Mondesert, O., & Russell, P. (1999) · Nature · doi:10.1038/16488 · Cited by 576
p53 modulation of TFIIH–associated nucleotide excision repair activity
Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J.-M., Wang, Z., Friedberg, E. C., Evans, M. K., Taffe, B. G., et al. (1995) · Nature Genetics · doi:10.1038/ng0695-188 · Cited by 554
DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation
Difilippantonio, M. J., Zhu, J., Chen, H. T., Meffre, E., Nussenzweig, M. C., Max, E. E., Ried, T., & Nussenzweig, A. (2000) · Nature · doi:10.1038/35006670 · Cited by 547
Cdc25 Mitotic Inducer Targeted by Chk1 DNA Damage Checkpoint Kinase
Furnari, B., Rhind, N., & Russell, P. (1997) · Science · doi:10.1126/science.277.5331.1495 · Cited by 539
Mitotic forces control a cell-cycle checkpoint
Li, X., & Nicklas, R. B. (1995) · Nature · doi:10.1038/373630a0 · Cited by 535
The INK4A/ARF locus and its two gene products.
Sharpless, N. E., & DePinho, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80004-5 · Cited by 533 · cited 1×
“A more accurate mapping of the INK4a locus has shown that it also encodes another protein, called p19ARF, which has a role in regulating p53 stability and which is frequently found to be mutated in cancer (Roussel 1999; Sharpless & DePinho 1999).”
BackgroundhCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
Lee, J.-S., Collins, K. M., Brown, A. L., Lee, C.-H., & Chung, J. H. (2000) · Nature · doi:10.1038/35004614 · Cited by 529
Rieder, C. L., Schultz, A., Cole, R., & Sluder, G. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.5.1301 · Cited by 508
Purification and Molecular Cloning of Plx1, a Cdc25-Regulatory Kinase from Xenopus Egg Extracts
Kumagai, A., & Dunphy, W. G. (1996) · Science · doi:10.1126/science.273.5280.1377 · Cited by 507
Cheng, M., Sexl, V., Sherr, C. J., & Roussel, M. F. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.3.1091 · Cited by 496 · cited 1×
“Addition of growth factors activate cell surface receptors and initiates a signalling cascade that induces cycD accumulation (Cheng et al. 1998, and references therein).”
BackgroundRegulation of cell proliferation by the E2F transcription factors
Helin, K. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80058-0 · Cited by 490
Heald, R., McLoughlin, M., & McKeon, F. (1993) · Cell · doi:10.1016/0092-8674(93)80048-j · Cited by 462
Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway
Chaturvedi, P., Eng, W. K., Zhu, Y., Mattern, M. R., Mishra, R., Hurle, M. R., Zhang, X., Annan, R. S., Lu, Q., Faucette, L. F., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202925 · Cited by 423
Amplification and expression of the human cyclin D gene in esophageal cancer.
Jiang, W. B., Kahn, S. M., Tomita, N., Zhang, Y. J., Lu, S., & Weinstein, I. B. (1992) · PubMed · Cited by 404
Amon, A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80010-0 · Cited by 395
Four-dimensional control of the cell cycle
Pines, J. (1999) · Nature Cell Biology · doi:10.1038/11041 · Cited by 389
Chan, G. K. T., Jablonski, S. A., Sudakin, V., Hittle, J. C., & Yen, T. J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.941 · Cited by 376
Liu, F., Stanton, J. J., Wu, Z., & Piwnica-Worms, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.571 · Cited by 376
Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R. J. A. M., Dickson, C., Arnold, A., & Peters, G. B. (1991) · PubMed · Cited by 371
Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer.
Jiang, W., Zhang, Y. J., Kahn, S. M., Hollstein, M. C., Santella, R. M., Lu, S. H., Harris, C. C., Montesano, R., & Weinstein, I. B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9026 · Cited by 360
Zhang, H. S., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)80714-x · Cited by 349
Shen, M., Stukenberg, P. T., Kirschner, M. W., & Lu, K. P. (1998) · Genes & Development · doi:10.1101/gad.12.5.706 · Cited by 340
Identification of Human and Mouse p19, a Novel CDK4 and CDK6 Inhibitor with Homology to p16ink4
Chan, F. K. M., Zhang, J., Cheng, L., Shapiro, D. N., & Winoto, A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2682 · Cited by 339
MPF localization is controlled by nuclear export
Hagting, A., Karlsson, C., Clute, P., Jackman, M., & Pines, J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.14.4127 · Cited by 334
Nuclear export of cyclin B1 and its possible role in the DNA damage-induced G2 checkpoint
Toyoshima, F. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2728 · Cited by 328
Krek, W., & Nigg, E. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04897.x · Cited by 323
The INK4 family of cell cycle inhibitors in cancer
Roussel, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202998 · Cited by 322
The cdc25B phosphatase is essential for the G 2/M phase transition in human cells
Lammer1, C., Wagerer, S., Saffrich, R., Mertens, D., Ansorge, W., & Hoffmann, I. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.16.2445 · Cited by 306
Kumagai, A., & Dunphy, W. G. (1999) · Genes & Development · doi:10.1101/gad.13.9.1067 · Cited by 305
The cell cycle and the retinoblastoma protein family
Ewen, M. E. (1994) · Cancer and Metastasis Reviews · doi:10.1007/bf00690418 · Cited by 303
Nuclear Localization of Cyclin B1 Controls Mitotic Entry After DNA Damage
Jin, P., Hardy, S., & Morgan, D. O. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.4.875 · Cited by 298
Gallant, P., & Nigg, E. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.1.213 · Cited by 295
Periodic changes in phosphorylation of the Xenopus cdc25 phosphatase regulate its activity.
Izumi, T., Walker, D. H., & Maller, J. L. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.8.927 · Cited by 293
C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding.
Peng, C. Y., Graves, P. R., Ogg, S., Thoma, R. S., Byrnes, M. J., Wu, Z., Stephenson, M. T., & Piwnica-Worms, H. M. (1998) · PubMed · Cited by 284
Dulić, V, Drullinger, L. F., Lees, E., Reed, S. I., & Stein, G. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11034 · Cited by 279 · cited 1×
“The Cip/Kip family includes p21CIP1 (Dulic et al. 1993; El-Deiry et al. 1993; Gu, Turck & Morgan 1993; Harper et al. 1993) p27KIP1 (Polyak et al. 1994; Toyoshima 1994), and p57KIP2 (Lee, Reynisdottir & Massague 1995; Matsuoka et al. 1995).”
ATM: A mediator of multiple responses to genotoxic stress
Rotman, G., & Shiloh, Y. (1999) · Oncogene · doi:10.1038/sj.onc.1203124 · Cited by 272
Pines, J., & Hunter, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06688.x · Cited by 268
Brown, A. L., Lee, C.-H., Schwarz, J. K., Mitiku, N., Piwnica-Worms, H., & Chung, J. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3745 · Cited by 261
Cdc2 tyrosine phosphorylation is required for the DNA damage checkpoint in fission yeast.
Rhind, N., Furnari, B., & Russell, P. (1997) · Genes & Development · doi:10.1101/gad.11.4.504 · Cited by 256
Role of inhibitory CDC2 phosphorylation in radiation-induced G2 arrest in human cells.
Jin, P., Gu, Y., & Morgan, D. O. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.4.963 · Cited by 250
Kallio, M., Weinstein, J., Daum, J. R., Burke, D. J., & Gorbsky, G. J. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.6.1393 · Cited by 240
Yang, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2174 · Cited by 239
Gabrielli, B. G., Souza, C. P. C. D., Tonks, I. D., Clark, J. M., Hayward, N. K., & Ellem, K. A. O. (1996) · Journal of Cell Science · doi:10.1242/jcs.109.5.1081 · Cited by 236
Cdc25 Inhibited In Vivo and In Vitro by Checkpoint Kinases Cds1 and Chk1
Furnari, B., Blasina, A., Boddy, M. N., McGowan, C. H., & Russell, P. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.4.833 · Cited by 219
Cell cycle regulation by the ubiquitin pathway
Pagano, M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.13.9367342 · Cited by 213
Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells.
Ryan, J. J., Danish, R., Gottlieb, C. A., & Clarke, M. F. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.711 · Cited by 195
Mechanisms of G2 Arrest in Response to Overexpression of p53
Taylor, W. R., DePrimo, S. E., Agarwal, A., Agarwal, M. L., Schönthal, A. H., Katula, K. S., & Stark, G. R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.11.3607 · Cited by 195
The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1
Crenshaw, D. G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1315 · Cited by 186
Cdc25b and Cdc25c Differ Markedly in Their Properties as Initiators of Mitosis
Karlsson, C., Katich, S., Hagting, A., Hoffmann, I., & Pines, J. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.3.573 · Cited by 178
Parry, D., Mahony, D., Wills, K., & Lees, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1775 · Cited by 174
Requirement of the Prolyl Isomerase Pin1 for the Replication Checkpoint
Winkler, K. E., Swenson, K. I., Kornbluth, S., & Means, A. R. (2000) · Science · doi:10.1126/science.287.5458.1644 · Cited by 172
Role of the tumor suppressor gene Brca1 in genetic stability and mammary gland tumor formation
Deng, C.-X., & Scott, F. (2000) · Oncogene · doi:10.1038/sj.onc.1203269 · Cited by 158
The PRAD‐1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas
Bártková, J., Lukas, J., Strauss, M., & Bártek, J. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580420 · Cited by 152
Cdc25 protein phosphatases in cell proliferation
Draetta, G. F., & Eckstein, J. W. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00049-2 · Cited by 148
Interaction of D-Type Cyclins with a Novel myb-Like Transcription Factor, DMP1
Hirai, H., & Sherr, C. J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6457 · Cited by 131
Izumi, T., & Maller, J. L. (1995) · Molecular Biology of the Cell · doi:10.1091/mbc.6.2.215 · Cited by 124
Nasmyth, K. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01358-4 · Cited by 120
Baldin, V., Cans, C., Knibiehler, M., & Ducommun, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.32731 · Cited by 119
Overexpression of cyclin D1 in mouse skin carcinogenesis.
Ab, B., Sm, F., Robles, A. I., et al. (1993) · PubMed · Cited by 117
Gabrielli, B. G., Clark, J. M., McCormack, A. K., & Ellem, K. A. O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28607 · Cited by 112
Nishijima, H., Nishitani, H., Seki, T., & Nishimoto, T. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.138.5.1105 · Cited by 88
Seki, T., Yamashita, K., Nishitani, H., Takagi, T., Russell, P. R., & Nishimoto, T. (1992) · Molecular Biology of the Cell · doi:10.1091/mbc.3.12.1373 · Cited by 70
Breast Cancer Genes and DNA Repair
Venkitaraman, A. R. (1999) · Science · doi:10.1126/science.286.5442.1100 · Cited by 69
7 DNA-dependent protein kinase and related proteins
Smith, G. C. M., Divecha, N., Lakin, N. D., & Jackson, S. P. (1999) · Princeton University Press eBooks · doi:10.1515/9781400865048.91 · Cited by 59
Badie, C., Bourhis, J., Sobczak‐Thépot, J., Haddada, H., Chiron, M., Janicot, M., Janot, F., Tursz, T., & Vassal, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.0976 · Cited by 47
Barth, H., Hoffmann, I., Klein‐Scory, S., Kaszkin, M., Richards, J., & Kinzel, V. (1996) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199609)168:3<589::aid-jcp11>3.0.co;2-v · Cited by 24
Cited by
Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype
Kumar, B., Koul, S., Khandrika, L., Meacham, R. B., & Koul, H. K. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5259 · Cited by 736
Hirai, H., Iwasawa, Y., Okada, M., Arai, T., Nishibata, T., Kobayashi, M., Kimura, T., Kaneko, N., Ohtani, J., Yamanaka, K., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0463 · Cited by 540
Effects of low dose quercetin: Cancer cell‐specific inhibition of cell cycle progression
Jeong, J., An, J. Y., Kwon, Y. T., Rhee, J. G., & Lee, Y. J. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21977 · Cited by 380
Mantena, S. K., Sharma, S. D., & Katiyar, S. K. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0448 · Cited by 353
Singh, S. V., Herman-Antosiewicz, A., Singh, A. V., Lew, K. L., Srivastava, S. K., Kamath, R., Brown, K. D., Zhang, L., & Baskaran, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313538200 · Cited by 347
Metadata
- Authors
- Molinari, M.
- Venue
- Cell Proliferation
- Publisher
- Wiley
- Published
- 2000-10
- Volume
- 33
- Issue
- 5
- Pages
- 261-274
- ISSN
- 0960-7722 (ISSN-L)
- 1365-2184
- OpenAlex
- W2129695021
- Cited by
- 388
- References
- 127
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.